chr3-133757117-A-G

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NM_001063.4(TF):c.870+108A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The gene TF is a known oncogene (CancerMine: 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.0131 (AC=18,691) in the gnomAD database across 1,427,962 control chromosomes, including 1,902 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.229. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (no review stars).

Frequency

Genomes: 𝑓 0.065 ( 1041 hom., cov: 32)
Exomes 𝑓: 0.0069 ( 861 hom. )

Consequence

TF
NM_001063.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.59

Publications

1 publications found
Variant links:
Genes affected
TF (HGNC:11740): (transferrin) This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009]
TF Gene-Disease associations (from GenCC):
  • atransferrinemia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: PanelApp Australia, ClinGen, Orphanet, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001063.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.229 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001063.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TF NM_001063.4
MANE Select
HGVSc / HGVSpc.870+108A>G
Exon rankIntron 7 of 16
intron
Prot: NP_001054.2UniProt: P02787Q06AH7A0PJA6
TF NM_001354703.2
HGVSc / HGVSpc.738+108A>G
Exon rankIntron 13 of 22
intron
Prot: NP_001341632.2
TF NM_001354704.2
HGVSc / HGVSpc.489+108A>G
Exon rankIntron 6 of 15
intron
Prot: NP_001341633.2

Ensembl Transcripts

TF ENST00000402696.9
TSL:1MANE Select
HGVSc / HGVSpc.870+108A>G
Exon rankIntron 7 of 16
intron
Prot: ENSP00000385834.3UniProt: P02787
TF ENST00000877249.1
HGVSc / HGVSpc.222+108A>G
Exon rankIntron 2 of 11
intron
Prot: ENSP00000547308.1UniProt: A0ACI8QAC3
TF ENST00000877246.1
HGVSc / HGVSpc.217-7065A>G
Exon rankIntron 2 of 9
intron
Prot: ENSP00000547305.1UniProt: A0ACI8R955

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.0650
AC:9889
Hom:1039
AN:152038
Cov:32
GnomAD4 exome
AF: 0.00688
AC:8782
Hom:861
AN:1275806
GnomAD4 genome
AF: 0.0651
AC:9909
Hom:1041
AN:152156
Cov:32
TOPMed (Bravo)
AF: 0.0745
AC:19716
Hom:2081
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0490
AC:2350
Hom:271
AN:47938
Local & regional cohorts 6 sources
ABraOM SABE-WGS-1171
AF: 0.0491
AC:115
Hom:5
AN:2342
GenomeAsia100K
AF: 0.0130
AC:48
AN:3478
Qatari Genome
AF: 0.0455
AC:8
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00000800
AC:1
Hom:0
AN:122720
Turkish Variome
AF: 0.000647
AC:1
Hom:0
AN:1546
UK10K
AF: 0.000397
AC:3
AN:7562
Showing 11 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00192 12665728 0.00135 173127892
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign9.2
BayesDel_noAF
Benign-0.78
CADD
Benign12
DANN
Benign0.81
GPN-Star LLR
N/A-0.76
GPN-Star score
N/A0.76
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign3.6
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.